XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity

The following table summarizes stock option activity during the nine months ended September 30, 2023:

						Shares						Weighted- Average  Exercise Price						Weighted- Average Remaining Contractual Term						Aggregate Intrinsic Value
						(in thousands)												(in years)						(in thousands)
Outstanding at December 31, 2022						2,443						6.01						4.7						$	7,674
Granted						—						—
Exercised						(265)						7.59
Cancelled/forfeited						(44)						8.35
Outstanding at September 30, 2023						2,134						5.77						4.0						$	28,657
Vested and exercisable at September 30, 2023						2,129						5.75						3.9						$	28,627

Schedule of RSU, PSU, MPSUs Activity

The following table summarizes RSU activity during the nine months ended September 30, 2023:

						Number of Shares						Weighted-Average  Grant Date Fair Value Per Share
						(in thousands)
Unvested RSUs as of December 31, 2022						11,990						$	20.10
Granted						6,897						15.74
Vested						(5,306)						19.01
Cancelled/forfeited						(1,280)						22.61
Unvested RSUs as of September 30, 2023						12,301						$	17.86

						Number of Shares						Weighted-Average Grant Date Fair Value Per Share
						(in thousands)
Nonvested PSUs as of December 31, 2022						267						$	28.16
Granted						762						15.88
Vested						(78)						28.16
Cancelled/forfeited						(122)						28.16
Nonvested PSUs as of September 30, 2023						829						$	16.87

						Number of Shares						Weighted-Average Grant Date Fair Value Per Share
						(in thousands)
Nonvested MPSUs as of December 31, 2022						2,174						$	6.80
Granted						87						7.25
Vested						—						—
Cancelled/forfeited						(100)						6.88
Nonvested MPSUs as of September 30, 2023						2,161						$	6.81

Schedule of Stock-Based Compensation Expense

The following table summarizes the components of total stock-based compensation expense included in the accompanying condensed consolidated statements of operations:

						Three months ended September 30,												Nine months ended September 30,
						2023						2022						2023						2022
						(in thousands)
Cost of revenue						$	2,860					$	2,978					$	8,378					$	9,112
Research and development						12,122						14,488						35,808						46,966
Sales and marketing						9,061						10,920						25,643						31,198
General and administrative						11,670						10,992						31,027						27,102
Total stock-based compensation expense						$	35,713					$	39,378					$	100,856					$	114,378

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding restricted stock units that are fully vested and expected to vest. Includes, but is not limited to, unvested restricted stock units for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(1)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockUnitsVestedAndExpectedToVestTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration